GB9215921D0 - Anti-inflammatory compounds - Google Patents
Anti-inflammatory compoundsInfo
- Publication number
- GB9215921D0 GB9215921D0 GB929215921A GB9215921A GB9215921D0 GB 9215921 D0 GB9215921 D0 GB 9215921D0 GB 929215921 A GB929215921 A GB 929215921A GB 9215921 A GB9215921 A GB 9215921A GB 9215921 D0 GB9215921 D0 GB 9215921D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- inflammatory compounds
- inflammatory
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929215921A GB9215921D0 (en) | 1992-07-27 | 1992-07-27 | Anti-inflammatory compounds |
TW082105933A TW246670B (en) | 1992-07-27 | 1993-07-26 | |
ZA935378A ZA935378B (en) | 1992-07-27 | 1993-07-26 | Anti-inflammatory compounds |
IL106472A IL106472A0 (en) | 1992-07-27 | 1993-07-26 | Hydroxamic acid derivatives,their preparation and pharmaceutical compositions containing them |
MX9304503A MX9304503A (en) | 1992-07-27 | 1993-07-26 | ANTI-INFLAMMATORY COMPOUNDS. |
EP93917925A EP0652864A1 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
JP6504325A JPH07509462A (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
CA002141214A CA2141214A1 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
PCT/GB1993/001585 WO1994002448A1 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
AU47170/93A AU672810B2 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929215921A GB9215921D0 (en) | 1992-07-27 | 1992-07-27 | Anti-inflammatory compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9215921D0 true GB9215921D0 (en) | 1992-09-09 |
Family
ID=10719360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB929215921A Pending GB9215921D0 (en) | 1992-07-27 | 1992-07-27 | Anti-inflammatory compounds |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0652864A1 (en) |
JP (1) | JPH07509462A (en) |
AU (1) | AU672810B2 (en) |
CA (1) | CA2141214A1 (en) |
GB (1) | GB9215921D0 (en) |
IL (1) | IL106472A0 (en) |
MX (1) | MX9304503A (en) |
TW (1) | TW246670B (en) |
WO (1) | WO1994002448A1 (en) |
ZA (1) | ZA935378B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE154932T1 (en) * | 1993-11-26 | 1997-07-15 | Pfizer | ISOXAZOLINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS |
CA2184914C (en) * | 1994-03-09 | 2000-09-19 | Victoria L. Cohan | Isoxazoline compounds as 5-lipoxygenase inhibitors |
JP3322885B2 (en) * | 1995-02-02 | 2002-09-09 | 日研化学株式会社 | N-hydroxyurea derivative |
WO1997029776A1 (en) | 1996-02-13 | 1997-08-21 | G.D. Searle & Co. | Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors |
PT880363E (en) | 1996-02-13 | 2002-12-31 | Searle & Co | COMBINATIONS WITH IMMUNOSUPPRESSOR EFFECTS CNTING A CICLOOXIGENASE-2 INHIBITOR AND A LEUCOTYRENE HYDROLASE INHIBITOR A4 |
DE69733338T2 (en) | 1996-02-13 | 2006-03-16 | G.D. Searle & Co., Chicago | PREPARATIONS, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIEN B4 RECEPTOR ANTAGONIST |
ATE224718T1 (en) * | 1996-06-25 | 2002-10-15 | Cephalon Inc | USE OF A K-252A DERIVATIVE TO TREAT PERIPHERAL OR CENTRAL NERVOUS DISEASES AND EXCESSIVE CYTOKINE PRODUCTION |
ATE228998T1 (en) * | 1997-07-31 | 2002-12-15 | Abbott Lab | N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF METALLOPROTEINASES |
US6235786B1 (en) | 1997-08-06 | 2001-05-22 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
US6294573B1 (en) | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
WO2000044712A1 (en) * | 1999-01-27 | 2000-08-03 | Abbott Laboratories | N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
SE0103325D0 (en) | 2001-10-04 | 2001-10-04 | Astrazeneca Ab | Novel compounds |
TW200946105A (en) | 2008-02-07 | 2009-11-16 | Kyorin Seiyaku Kk | Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU602485B2 (en) * | 1985-03-16 | 1990-10-18 | Wellcome Foundation Limited, The | Lipoxygenase and/or cyclooxygenase inhibitory compounds |
PL154186B1 (en) * | 1987-07-15 | 1991-07-31 | Wellcome Found | Method for manufacturing arylic derivatives of the hydroxamic acid |
DK0540673T3 (en) * | 1990-07-25 | 1997-03-24 | Abbott Lab | Acetylene derivatives with lipoxygenase inhibitory effect |
JPH06256285A (en) * | 1990-12-11 | 1994-09-13 | Pfizer Pharmaceut Co Ltd | Hydroxamic acid derivative and its use |
-
1992
- 1992-07-27 GB GB929215921A patent/GB9215921D0/en active Pending
-
1993
- 1993-07-26 TW TW082105933A patent/TW246670B/zh active
- 1993-07-26 MX MX9304503A patent/MX9304503A/en unknown
- 1993-07-26 IL IL106472A patent/IL106472A0/en unknown
- 1993-07-26 ZA ZA935378A patent/ZA935378B/en unknown
- 1993-07-27 WO PCT/GB1993/001585 patent/WO1994002448A1/en not_active Application Discontinuation
- 1993-07-27 CA CA002141214A patent/CA2141214A1/en not_active Abandoned
- 1993-07-27 EP EP93917925A patent/EP0652864A1/en not_active Withdrawn
- 1993-07-27 AU AU47170/93A patent/AU672810B2/en not_active Ceased
- 1993-07-27 JP JP6504325A patent/JPH07509462A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU672810B2 (en) | 1996-10-17 |
IL106472A0 (en) | 1993-11-15 |
TW246670B (en) | 1995-05-01 |
AU4717093A (en) | 1994-02-14 |
JPH07509462A (en) | 1995-10-19 |
MX9304503A (en) | 1994-04-29 |
EP0652864A1 (en) | 1995-05-17 |
CA2141214A1 (en) | 1994-02-03 |
WO1994002448A1 (en) | 1994-02-03 |
ZA935378B (en) | 1995-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9300508A0 (en) | Compounds | |
GB9200245D0 (en) | Compounds | |
GB9201755D0 (en) | Compounds | |
GB9200210D0 (en) | Compounds | |
GB9201694D0 (en) | Compounds | |
GB9201693D0 (en) | Compounds | |
GB9200209D0 (en) | Compounds | |
ZA935378B (en) | Anti-inflammatory compounds | |
GB9200566D0 (en) | Compounds | |
GB9201751D0 (en) | Compounds | |
GB9202792D0 (en) | Compounds | |
GB9201692D0 (en) | Compounds | |
GB9308652D0 (en) | Anti-inflammatory compounds | |
GB9205859D0 (en) | Compounds | |
GB9216682D0 (en) | Anti-inflammatory compounds | |
GB9223161D0 (en) | Anti-inflammatory compounds | |
GB9203512D0 (en) | Anti-inflammatory compounds | |
GB9318432D0 (en) | Anti-inflammatory compounds | |
GB9119554D0 (en) | Anti-inflammatory compounds | |
GB9203919D0 (en) | Pharmaceutical anti-inflammatory compounds | |
GB9203171D0 (en) | Compounds | |
GB9203182D0 (en) | Compounds | |
GB9203170D0 (en) | Compounds | |
GB9201747D0 (en) | Compounds | |
GB9203172D0 (en) | Compounds |